The vector potential of Culicoides variipennis for Rift Valley fever virus (RVFV) was investigated. Insects from a colony maintained at the Animal Virus Research Institute, Pirbright, were fed through a membrane on a mixture of mouse blood and RVFV (virus concentration of blood meal 7 X 95 log10 MLD50ml). Engorged insects were maintained at 25 degrees C +/- 1 degrees C. Samples of insects were tested at daily intervals to determine their virus content. Four of the five females tested immediately after feeding contained virus. The mean virus concentration of these infected flies was 2 X 7 log10MLD50. The virus concentration per fly decreased to 0 by day 2 post infection. On day 3, a virus concentration of 2 X 4 log10 MLD50 per fly was recorded from a pool of 17 flies but between day 4 and day 12 when the experiment terminated no virus was detected in any of the 135 females tested. Because of the pathogenic nature of RVFV, this work was carried out under the stringent security regulations at the PHLS Centre for Applied Microbiology and Research, Porton Down. The problems arising from experiments requiring the handling and infection of insects under such conditions are described.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0035-9203(82)90216-4DOI Listing

Publication Analysis

Top Keywords

virus concentration
16
virus
10
culicoides variipennis
8
rift valley
8
valley fever
8
fever virus
8
females tested
8
susceptibility culicoides
4
variipennis coq
4
coq diptera
4

Similar Publications

Exploring Tetraselmis chui microbiomes-functional metagenomics for novel catalases and superoxide dismutases.

Appl Microbiol Biotechnol

January 2025

Department of Microbiology and Biotechnology, Institute of Plant Science and Microbiology, University of Hamburg, Ohnhorststr.18, 22609, Hamburg, Germany.

The focus on microalgae for applications in several fields, e.g. resources for biofuel, the food industry, cosmetics, nutraceuticals, biotechnology, and healthcare, has gained increasing attention over the last decades.

View Article and Find Full Text PDF

Fit for purpose testing and independent GMP validation of the monocyte activation test.

Curr Res Toxicol

December 2024

Large Molecule Analytical Development, Janssen Biologics LLC (a Johnson and Johnson Company), 200 Great Valley Parkway, Malvern, PA 19355 USA.

The present study describes the "fit for purpose" testing and the independent product-specific GMP validation of the monocyte activation test (MAT) to detect pyrogenic and pro-inflammatory contaminants, MAT Method A, Quantitative Test (European Pharmacopoeia, Ph. Eur. chapter 2.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic highlighted the need for improved infectious aerosol concentrations through interventions that reduce the transmission of airborne infections. The aims of this review were to map the existing literature on interventions used to improve infectious aerosol concentrations in hospitals and understand challenges in their implementation.

Methods: We reviewed peer-reviewed articles identified on three databases, MEDLINE, Web of Science, and the Cochrane Library from inception to July 2024.

View Article and Find Full Text PDF

HBx Facilitates Drug Resistance in Hepatocellular Carcinoma via CD133-regulated Self-renewal of Liver Cancer Stem Cells.

J Clin Transl Hepatol

January 2025

Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

Background And Aims: Hepatitis B virus (HBV) infection contributes to hepatocellular carcinoma (HCC) tumorigenesis, drug resistance, and recurrence, although the underlying molecular mechanisms remain unclear. Recent studies suggest that HBV infection may be associated with liver cancer stem cells (LCSCs), but the exact mechanisms are yet to be resolved. In this study, we aimed to analyze the role of HBV infection in regulating the stemness of HCCs, which is closely linked to drug resistance.

View Article and Find Full Text PDF

Enterococcus species, natural inhabitants of the human gut, have become major causes of life-threatening bloodstream infections (BSIs) and the third most frequent cause of hospital-acquired bacteremia. The rise of high-level gentamicin resistance (HLGR) in enterococcal isolates complicates treatment and revives bacteriophage therapy. This study isolated and identified forty E.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!